ONC BeOne Medicines Ltd. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
04:28
Jul 23
FirstSquawk Newswire (@FirstSquawk)
J.P. Morgan raises BeiGene price target to $425 following an updated outlook on the company.
ONC
13:30
Feb 04 ◎
Bob Mosh President and CEO, Cencora, Inc. COR Q1 FY26 call
The UUG subsidiary's joint venture interest and non-controlling loss add-back are new, below-the-line contributions to Cencora's net income, separate from the operating income contribution.
ONC
HIGH

About ONC Analyst Coverage

Buzzberg tracks ONC (BeOne Medicines Ltd.) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: FirstSquawk, Bob Mosh.